Investor Overview
News
- Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health SummitFebruary 18, 2020 8:30 AM EST
- Kindred Biosciences Announces Half-Life Extension Technology for Canine AntibodiesJanuary 8, 2020 4:02 PM EST
- Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in DogsDecember 16, 2019 8:02 AM EST
Events
- Monday, February 24, 2020 from 12:50 PM to 1:30 PM EST
- Wednesday, January 8, 2020 4:30 PM EST
- Thursday, November 21, 2019
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Investor Overview
Kindred Biosciences Inc at the Bank of America Merrill Lynch Animal Health Summit
Monday, February 24, 2020 from 12:50 PM to 1:30 PM EST
KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co...
Stock Information
News
Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health Summit
February 18, 2020
SAN FRANCISCO , Feb. 18, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ...
Kindred Biosciences Announces Half-Life Extension Technology for Canine Antibodies
January 8, 2020
- Positive results from canine pharmacokinetic study demonstrate up to three-fold...
Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in Dogs
December 16, 2019
SAN FRANCISCO , Dec. 16, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...